Viktor Grünwald
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 184
- Sarcoma Diagnosis and Treatment 20
- Prostate Cancer Treatment and Research 19
- Oncology 107
- Cancer Immunotherapy and Biomarkers 57
- Co-authors
- Camillo Porta (43 shared papers)Bernard Escudier (29 shared papers)Manuel Hidalgo (7 shared papers)Robert J. Motzer (43 shared papers)Thomas E. Hutson (32 shared papers)Alain Ravaud (16 shared papers)Sergio Bracarda (15 shared papers)Stéphane Oudard (10 shared papers)
- Journals
- Journal of Clinical Oncology (64 papers)Annals of Oncology (32 papers)European Journal of Cancer (22 papers)World Journal of Urology (13 papers)European Urology (12 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Viktor Grünwald
302 papers receiving 10.4k citations
Viktor Grünwald's Hit Papers
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 6.0k
- Cancer Research 1.9k
- Oncology 3.0k
- Molecular Biology 3.9k
- Genetics 335
Countries citing papers authored by Viktor Grünwald
This map shows the geographic impact of Viktor Grünwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Grünwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Grünwald more than expected).
Fields of papers citing papers by Viktor Grünwald
This network shows the impact of papers produced by Viktor Grünwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Grünwald. The network helps show where Viktor Grünwald may publish in the future.
Co-authors
The 25 scholars most cited alongside Viktor Grünwald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 337 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Hit paper breakdown → | 2008 | 2345 |
| 2 | Phase 3 trial of everolimus for metastatic renal cell carcinoma Hit paper breakdown → | 2010 | 905 |
| 3 | Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2019 | 798 |
| 4 | 2016 | 311 | |
| 5 | 2003 | 301 | |
| 6 | Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. | 2002 | 227 |
| 7 | 2019 | 189 | |
| 8 | 2013 | 184 | |
| 9 | 2011 | 175 | |
| 10 | 2016 | 157 | |
| 11 | 2016 | 153 | |
| 12 | Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients. | 2003 | 149 |
| 13 | 2004 | 146 | |
| 14 | 2021 | 130 | |
| 15 | 2011 | 128 | |
| 16 | Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2024 | 127 |
| 17 | 2009 | 108 | |
| 18 | 2011 | 106 | |
| 19 | 2017 | 94 | |
| 20 | Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches Hit paper breakdown → | 2023 | 88 |
About Viktor Grünwald
Viktor Grünwald is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 337 papers that have together received 10.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (184 papers), Renal and related cancers (57 papers), Cancer Immunotherapy and Biomarkers (57 papers), Cancer Genomics and Diagnostics (51 papers), Bladder and Urothelial Cancer Treatments (35 papers), Economic and Financial Impacts of Cancer (23 papers), Sarcoma Diagnosis and Treatment (20 papers) and Prostate Cancer Treatment and Research (19 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.0k citations), Cancer Research (1.9k citations), Oncology (3.0k citations), Molecular Biology (3.9k citations) and Genetics (335 citations). Viktor Grünwald has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Camillo Porta, Bernard Escudier, Manuel Hidalgo, Robert J. Motzer, Thomas E. Hutson, Alain Ravaud, Sergio Bracarda, Stéphane Oudard, Robert A. Figlin and John A. Thompson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, World Journal of Urology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.